Login / Signup

Time to treatment with bridging intravenous alteplase before endovascular treatment:subanalysis of the randomized controlled SWIFT-DIRECT trial.

Thomas Raphael MeinelJohannes KaesmacherLukas BuetikoferDaniel StrbianOmer Faruk EkerChristophe CognardPasquale MordasiniSandro DeppelerVitor Mendes PereiraJean François AlbucherJean DarcourtRomain BourcierBenoit GuillonChrisanthi PapagiannakiGuillaume CostentinGerli SiboltSilja RätyBenjamin GorySébastien RichardJan LimanMarielle ErnstMarion BoulangerCharlotte BarbierLaura MechtouffLiqun ZhangGaultier MarnatIgor SibonOmid NikoubashmanArno ReichArturo ConsoliDavid WeisenburgerManuel Requena RuizAlvaro Garcia-Tornel Garcia-CambaSuzana SalemeSolène MoulinPaolo PaganoGuillaume SaliouEmmanuel CarreraKevin JanotMarti BoixRaoul PopLucie Della SchiavaAndreas LuftMichel PiotinJean Christophe GentricAleksandra PikulaWaltraud PfeilschifterMarcel ArnoldAdnan SiddiquiMichael T FroehlerAnthony J FurlanRené ChapotMartin WiesmannPaolo MachiHans-Christoph DienerZsolt KulcsarLeo BonatiClaudio BassettiSimon EscalardDavid S LiebeskindJeffrey L SaverUrs FischerJan Grallanull null
Published in: Journal of neurointerventional surgery (2022)
gov ; Unique identifier: NCT03192332.
Keyphrases
  • endovascular treatment
  • phase iii
  • phase ii
  • open label
  • double blind
  • clinical trial
  • study protocol
  • placebo controlled
  • high dose
  • randomized controlled trial
  • acute ischemic stroke
  • low dose
  • replacement therapy